179 related articles for article (PubMed ID: 2535499)
1. Involvement of the acyl chain of ceramide in carbohydrate recognition by an anti-glycolipid monoclonal antibody: the case of an anti-melanoma antibody, M2590, to GM3-ganglioside.
Itonori S; Hidari K; Sanai Y; Taniguchi M; Nagai Y
Glycoconj J; 1989; 6(4):551-60. PubMed ID: 2535499
[TBL] [Abstract][Full Text] [Related]
2. Antigenicity of the carbohydrate moiety of ganglioside GM3 having 3-O-acetyl ceramide.
Daino T; Tsuchihashi K; Kashiwagi M; Yachida Y; Akino T; Gasa S
Glycoconj J; 1999 Jan; 16(1):39-43. PubMed ID: 10580649
[TBL] [Abstract][Full Text] [Related]
3. Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma.
Hirabayashi Y; Hamaoka A; Matsumoto M; Matsubara T; Tagawa M; Wakabayashi S; Taniguchi M
J Biol Chem; 1985 Oct; 260(24):13328-33. PubMed ID: 2414279
[TBL] [Abstract][Full Text] [Related]
4. A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors.
Carr A; Mullet A; Mazorra Z; Vázquez AM; Alfonso M; Mesa C; Rengifo E; Pérez R; Fernández LE
Hybridoma; 2000 Jun; 19(3):241-7. PubMed ID: 10952412
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a glioma-related ganglioside, O-Ac GM3 having 3-O-Ac ceramide and its substrate property toward hydrolases.
Tsuchihashi K; Daino T; Akino T; Gasa S
J Lipid Res; 1996 Oct; 37(10):2136-44. PubMed ID: 8906591
[TBL] [Abstract][Full Text] [Related]
6. An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo.
Dohi T; Nores G; Hakomori S
Cancer Res; 1988 Oct; 48(20):5680-5. PubMed ID: 3167827
[TBL] [Abstract][Full Text] [Related]
7. Novel modification of ceramide: rat glioma ganglioside GM3 having 3-O-acetylated sphingenine.
Suetake K; Tsuchihashi K; Inaba K; Chiba M; Ibayashi Y; Hashi K; Gasa S
FEBS Lett; 1995 Mar; 361(2-3):201-5. PubMed ID: 7698323
[TBL] [Abstract][Full Text] [Related]
8. [GM3 ganglioside as melanoma specific antigen and its biological function].
Hirabayashi Y; Taniguchi M
Hum Cell; 1989 Mar; 2(1):63-9. PubMed ID: 2535260
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers.
Hoon DS; Wang Y; Sze L; Kanda H; Watanabe T; Morrison SL; Morton DL; Irie RF
Cancer Res; 1993 Nov; 53(21):5244-50. PubMed ID: 7916649
[TBL] [Abstract][Full Text] [Related]
10. [Ganglioside GM3 from horse erythrocytes: structure and effect on cell proliferation].
Menzeleev RF; Smirnova GP; Chekareva NV; Zvonkova EN; Krasnopol'skiĭ IuM; Shvets VI
Bioorg Khim; 1993 Aug; 19(8):817-24. PubMed ID: 8379955
[TBL] [Abstract][Full Text] [Related]
11. Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3.
Yamamoto S; Yamamoto T; Saxton RE; Hoon DS; Irie RF
J Natl Cancer Inst; 1990 Nov; 82(22):1757-60. PubMed ID: 1700134
[TBL] [Abstract][Full Text] [Related]
12. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
Kawashima I; Kotani M; Ozawa H; Suzuki M; Tai T
Int J Cancer; 1994 Jul; 58(2):263-8. PubMed ID: 8026889
[TBL] [Abstract][Full Text] [Related]
13. Structure and molecular interactions of a unique antitumor antibody specific for N-glycolyl GM3.
Krengel U; Olsson LL; Martínez C; Talavera A; Rojas G; Mier E; Angström J; Moreno E
J Biol Chem; 2004 Feb; 279(7):5597-603. PubMed ID: 14627696
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2.
Karlsson G; Månsson JE; Wikstrand C; Bigner D; Svennerholm L
Biochim Biophys Acta; 1990 Apr; 1043(3):267-72. PubMed ID: 1691018
[TBL] [Abstract][Full Text] [Related]
15. The resolution into molecular species on desorption of glycolipids from thin-layer chromatograms, using combined thin-layer chromatography and fast-atom-bombardment mass spectrometry.
Karlsson KA; Lanne B; Pimlott W; Teneberg S
Carbohydr Res; 1991 Dec; 221():49-61. PubMed ID: 1816925
[TBL] [Abstract][Full Text] [Related]
16. GM3 as a target of anti-lymphocytic ganglioside antibodies in AIDS patients.
Misasi R; Sorice M; Griggi T; d'Agostino F; Garofalo T; Masala C; Pontieri GM; Lenti L
Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):216-23. PubMed ID: 8500269
[TBL] [Abstract][Full Text] [Related]
17. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen.
Nores GA; Dohi T; Taniguchi M; Hakomori S
J Immunol; 1987 Nov; 139(9):3171-6. PubMed ID: 3668254
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of leukemic lymphoblasts of T-cell and B-cell precursor origin with monoclonal anti-GD3 and anti-GM3 antibodies.
Merritt WD; Sztein MB; Taylor B; Reaman GH
Leukemia; 1991 Dec; 5(12):1087-91. PubMed ID: 1774957
[TBL] [Abstract][Full Text] [Related]
19. A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo.
Carr A; Mazorra Z; Alonso DF; Mesa C; Valiente O; Gomez DE; Perez R; Fernandez LE
Melanoma Res; 2001 Jun; 11(3):219-27. PubMed ID: 11468510
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of mouse monoclonal antibody M2590 against B16 melanoma cells with chemically synthesized GM3 ganglioside.
Hirabayashi Y; Sugimoto M; Ogawa T; Matsumoto M; Tagawa M; Taniguchi M
Biochim Biophys Acta; 1986 Jan; 875(1):126-8. PubMed ID: 3940532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
